Green Cross Of S. Korea Said Freed To Take Orders For H1N1 Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
South Korea's Green Cross said its H1N1 influenza vaccine GCFlu has been approved for marketing by the Korea FDA, ending the nation's reliance on imports and freeing the company to take orders for its drug. Green Cross said it would have produced by the end of July enough doses for 3.3 million, rising to 5 million people covered by the end of the year. South Korea thus becomes the world's 12 vaccine producer. (Click here for more
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.